help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crave, J. C.
Right arrow Articles by Pugeat, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crave, J. C.
Right arrow Articles by Pugeat, M.

Journal of Clinical Endocrinology & Metabolism, Vol 80, 1283-1289, Copyright © 1995 by Endocrine Society


ARTICLES

Differential effects of insulin and insulin-like growth factor I on the production of plasma steroid-binding globulins by human hepatoblastoma- derived (Hep G2) cells

JC Crave, H Lejeune, C Brebant, C Baret and M Pugeat
Laboratoire de la Clinique Endocrinologique, Hopital de l'Antiquaille, Lyon, France.

Changes in the plasma levels of corticosteroid-binding globulin (CBG) and sex hormone-binding globulin (SHBG) from birth to adulthood suggest that growth factors might influence clearance and/or hepatic secretion of CBG and SHBG in humans. The effects of insulin-like growth factor I (IGF-I) and insulin on CBG and SHBG synthesis by a clone of human hepatoblastoma-derived (Hep G2) cell lines were therefore investigated. The results showed that the immunoconcentrations of CBG and SHBG, as well as total protein concentration in culture medium from Hep G2 cells, were decreased by IGF-I and insulin. However, although the CBG- to-total protein ratio was decreased dose dependently by IGF-I and insulin, IGF-I and insulin did not dose-dependently decrease the SHBG- to-total protein ratio. The steady state levels of CBG and SHBG messenger RNAs (mRNAs) were reduced dose dependently by IGF-I with a half-effect at 5.4 +/- 1.9 and 4.6 +/- 1.6 nmol/L, respectively, and by insulin with a half-effect at 4.3 +/- 1.1 and 4.3 +/- 1.4 nmol/L, respectively. The maximum inhibitory effect of IGF-I on CBG mRNA level was 48 +/- 17% of control values and 60 +/- 13% for SHBG mRNA level. The changes in CBG mRNA levels were quantitatively similar to the changes in CBG immunoconcentration in the Hep G2 medium. In contrast, the inhibitory effects of insulin were only 17 +/- 8% and 31 +/- 12% of control values on CBG and SHBG mRNAs and 37 +/- 4% and 43 +/- 4% on CBG and SHBG concentrations, respectively. These results demonstrate that IGF-I reduces CBG and SHBG production by Hep G2 cells by decreasing mRNA steady state levels. The discrepancy between the inhibitory effects of insulin on CBG and SHBG mRNAs and protein secretion suggests that insulin exercises its inhibitory effects mainly on the mechanism(s) of translation and/or excretion of CBG and SHBG. The respective effects of IGF-I and insulin in the regulation of CBG and SHBG levels during fetal life and pubertal development in humans merit further study.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
S. Khosla, S. Amin, and E. Orwoll
Osteoporosis in Men
Endocr. Rev., June 1, 2008; 29(4): 441 - 464.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. A Mohr, S. Bhasin, C. L Link, A. B O'Donnell, and J. B McKinlay
The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study
Eur. J. Endocrinol., September 1, 2006; 155(3): 443 - 452.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Kupelian, S. T. Page, A. B. Araujo, T. G. Travison, W. J. Bremner, and J. B. McKinlay
Low Sex Hormone-Binding Globulin, Total Testosterone, and Symptomatic Androgen Deficiency Are Associated with Development of the Metabolic Syndrome in Nonobese Men
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 843 - 850.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. P. Peeters, A. W. van den Beld, H. van Toor, A. G. Uitterlinden, J. A. M. J. L. Janssen, S. W. J. Lamberts, and T. J. Visser
A Polymorphism in Type I Deiodinase Is Associated with Circulating Free Insulin-Like Growth Factor I Levels and Body Composition in Humans
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 256 - 263.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
P. MUTI
The Role of Endogenous Hormones in the Etiology and Prevention of Breast Cancer: The Epidemiological Evidence
Ann. N.Y. Acad. Sci., December 1, 2004; 1028(1): 273 - 282.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P.-H. Ducluzeau, P. Cousin, E. Malvoisin, H. Bornet, H. Vidal, M. Laville, and M. Pugeat
Glucose-to-Insulin Ratio Rather than Sex Hormone-Binding Globulin and Adiponectin Levels Is the Best Predictor of Insulin Resistance in Nonobese Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3626 - 3631.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. M. Fernandez-Real and W. Ricart
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Endocr. Rev., June 1, 2003; 24(3): 278 - 301.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
E. W.C.M. van Dam, J. M. Dekker, E. G.W.M. Lentjes, F. P.T.H.M. Romijn, Y. M. Smulders, W. J. Post, J. A. Romijn, and H. M. J. Krans
Steroids in Adult Men With Type 1 Diabetes: A tendency to hypogonadism
Diabetes Care, June 1, 2003; 26(6): 1812 - 1818.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. M. Joyner, L. J. Hutley, A. W. Bachmann, D. J. Torpy, and J. B. Prins
Greater replication and differentiation of preadipocytes in inherited corticosteroid-binding globulin deficiency
Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E1049 - E1054.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. M. Kalish, E. Barrett-Connor, G. A. Laughlin, and B. I. Gulanski
Association of Endogenous Sex Hormones and Insulin Resistance among Postmenopausal Women: Results from the Postmenopausal Estrogen/Progestin Intervention Trial
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1646 - 1652.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
L. Cordain, S. Lindeberg, M. Hurtado, K. Hill, S. B. Eaton, and J. Brand-Miller
Acne Vulgaris: A Disease of Western Civilization
Arch Dermatol, December 1, 2002; 138(12): 1584 - 1590.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-M. Fernandez-Real, M. Pugeat, M. Grasa, M. Broch, J. Vendrell, J. Brun, and W. Ricart
Serum Corticosteroid-Binding Globulin Concentration and Insulin Resistance Syndrome: A Population Study
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4686 - 4690.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. A. Laughlin, E. Barrett-Connor, D. Kritz-Silverstein, and D. von Mühlen
Hysterectomy, Oophorectomy, and Endogenous Sex Hormone Levels in Older Women: The Rancho Bernardo Study
J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 645 - 651.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J.-M. Fernández-Real, M. Grasa, R. Casamitjana, M. Pugeat, C. Barret, and W. Ricart
Plasma Total and Glycosylated Corticosteroid-Binding Globulin Levels Are Associated with Insulin Secretion
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3192 - 3196.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Emptoz-Bonneton, J. C. Crave, H. Lejeune, C. Brebant, and M. Pugeat
Corticosteroid-Binding Globulin Synthesis Regulation by Cytokines and Glucocorticoids in Human Hepatoblastoma-Derived (HepG2) Cells
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3758 - 3762.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society